Current Treatment Options in Oncology

, Volume 8, Issue 4, pp 322–330

Radiofrequency Thermal Ablation of Metastatic Neuroendocrine Tumors in the Liver


  • Peter J. Mazzaglia
    • Department of Surgery A-80Cleveland Clinic Foundation
  • Eren Berber
    • Department of Surgery A-80Cleveland Clinic Foundation
    • Department of Surgery A-80Cleveland Clinic Foundation
Endocrine Tumors

DOI: 10.1007/s11864-007-0038-9

Cite this article as:
Mazzaglia, P.J., Berber, E. & Siperstein, A.E. Curr. Treat. Options in Oncol. (2007) 8: 322. doi:10.1007/s11864-007-0038-9

Opinion Statement

In our armamentarium against neuroendocrine hepatic metastases, radiofrequency thermal ablation has proven to play a valuable role. Patients with neuroendocrine malignancies that progress to hepatic metastases may suffer not only from the hormonal sequelae of their disease, but also face the specter of death within several years from progressive hepatic replacement. For the majority of these patients who are not surgical candidates due to the extent of liver involvement, radiofrequency thermal ablation represents a low-risk treatment modality effective at both symptom alleviation and survival prolongation. Utilizing a laparoscopic approach guided by intra-operative ultrasound, effective tumor ablation can be achieved with minimal morbidity and low rates of local tumor recurrence.

Download to read the full article text

Copyright information

© Current Science Inc. 2007